Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Starting from an already known MMP-13 inhibitor, 1, we pursued an SAR-approach focusing on optimizing interactions close to the Zn binding site of the enzyme. We found the oxetane containing compound 32 (MMP-13 IC = 42 nM), which exhibited complete inhibition of collagenolysis in in vitro studies and an excellent selectivity profile among the MMP family. Interestingly, docking studies propose that the oxetane ring in 32 is oriented towards the Zn ion for chelating the metal ion. Chelating properties of MMP13-inhibitors are often connected with non-selectivity within the enzyme family. Compound 32 demonstrates a rare example where the selectivity can be explained via combinatorial effects of interactions within the S' loop and a chelating effect of the oxetane moiety. Furthermore, in vivo pharmacokinetic studies were performed demonstrating a concentration of 1.97 μM of 32 within the synovial fluid of the rat knee joint, which makes the compound a promising lead compound for further optimization and development for osteoarthritis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2022.129014DOI Listing

Publication Analysis

Top Keywords

mmp-13 inhibitor
8
ion chelating
8
development putative
4
putative zn-chelating
4
zn-chelating highly
4
highly selective
4
selective mmp-13
4
inhibitor starting
4
starting mmp-13
4
inhibitor pursued
4

Similar Publications

Matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) significantly impact articular cartilage biomechanical properties in osteoarthritis (OA). However, comprehensive understanding of biomechanical responses and the efficacy of potential therapeutic interventions remains limited. This study investigates how MMPs and ADAMTS synergistically degenerate cartilage biomechanical properties under different loading conditions, and evaluates the preventive role of cartilage oligomeric matrix protein (COMP) and tissue inhibitor of metalloproteinase-3 (TIMP-3).

View Article and Find Full Text PDF

Collagenases (MMP-1, MMP-8, and MMP-13) play significant roles in the pathophysiology of osteoarthritis. Among these proteins, MMP-13 and MMP-8 are known for their catabolic roles in the degradation of the articular cartilage matrix. Using computational studies, we had previously observed that a metabolite of curcumin, Curcumin monoglucuronide (CMG), binds to MMPs involved in cartilage matrix destruction.

View Article and Find Full Text PDF

Studies have shown an association between matrix metalloproteinases (MMPs) along with tissue inhibitors of MMPs (TIMP) and human immunodeficiency virus (HIV) infection and CD4 T cell count, a key clinical indicator for HIV progression, but the causality remains unclear. This study aimed to investigate the bidirectional causal relationship between MMPs/TIMP and HIV. A genome-wide association study-based two-sample bidirectional Mendelian randomization (MR) analysis was conducted to elucidate the potential causal links between MMPs/TIMP and HIV.

View Article and Find Full Text PDF

Objective: Postmenopausal women exhibit a higher incidence of osteoarthritis (OA) than age-matched men. This study aimed to investigate the effects of osteoclasts under estrogen deficiency on chondrocytes and to elucidate the associated molecular mechanisms.

Design: Rat ovariectomy-induced OA (OVX-OA) model was employed to induce bone loss and cartilage degeneration.

View Article and Find Full Text PDF

Purpose/aim: Temsirolimus is a water-soluble mammalian target of rapamycin (mTOR) complex inhibitor, potentially suitable for intra-articular administration. The present study aims to evaluate the therapeutic effects of intra-articular administration of temsirolimus on human chondrocytes and osteoarthritis (OA) progression in mice.

Materials And Methods: The beneficial effects of temsirolimus treatment were evaluated in human chondrocytes (Normal Human Articular Chondrocyte-Knee cells) with or without treatment with IL-1β by real-time polymerase chain reaction, TUNEL staining for apoptosis, and CYTO-ID(R) staining for autophagy.

View Article and Find Full Text PDF